Literature DB >> 33024328

Towards treating progressive multiple sclerosis.

Alan Thompson1, Olga Ciccarelli2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33024328     DOI： 10.1038/s41582-020-00421-4

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

Review 1.  Serum neurofilament light as a biomarker in progressive multiple sclerosis.

Authors:  Raju Kapoor; Kathryn E Smith; Mark Allegretta; Douglas L Arnold; William Carroll; Manuel Comabella; Roberto Furlan; Christopher Harp; Jens Kuhle; David Leppert; Tatiana Plavina; Finn Sellebjerg; Caroline Sincock; Charlotte E Teunissen; Ilir Topalli; Florian von Raison; Elizabeth Walker; Robert J Fox
Journal:  Neurology       Date:  2020-07-16       Impact factor: 9.910
  1 in total
  6 in total

Review 1.  Positron emission tomography in multiple sclerosis - straight to the target.

Authors:  Benedetta Bodini; Matteo Tonietto; Laura Airas; Bruno Stankoff
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

Review 2.  The role of glial cells in multiple sclerosis disease progression.

Authors:  Luke M Healy; Jo Anne Stratton; Tanja Kuhlmann; Jack Antel
Journal:  Nat Rev Neurol       Date:  2022-02-21       Impact factor: 44.711

Review 3.  Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.

Authors:  Alan J Thompson; William Carroll; Olga Ciccarelli; Giancarlo Comi; Anne Cross; Alexis Donnelly; Anthony Feinstein; Robert J Fox; Anne Helme; Reinhard Hohlfeld; Robert Hyde; Pamela Kanellis; Douglas Landsman; Catherine Lubetzki; Ruth Ann Marrie; Julia Morahan; Xavier Montalban; Bruno Musch; Sarah Rawlings; Marco Salvetti; Finn Sellebjerg; Caroline Sincock; Kathryn E Smith; Jon Strum; Paola Zaratin; Timothy Coetzee
Journal:  Mult Scler       Date:  2021-12-01       Impact factor: 6.312

4.  CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis.

Authors:  Manuel Comabella; Jaume Sastre-Garriga; Eva Borras; Luisa M Villar; Albert Saiz; Sergio Martínez-Yélamos; Juan Antonio García-Merino; Rucsanda Pinteac; Nicolas Fissolo; Antonio J Sánchez López; Lucienne Costa-Frossard; Yolanda Blanco; Sara Llufriu; Angela Vidal-Jordana; Eduard Sabidó; Xavier Montalban
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-09-08

5.  Choroid plexus-selective inactivation of adenosine A2A receptors protects against T cell infiltration and experimental autoimmune encephalomyelitis.

Authors:  Wu Zheng; Yijia Feng; Zhenhai Zeng; Mengqian Ye; Mengru Wang; Xin Liu; Ping Tang; Huiping Shang; Xiaoting Sun; Xiangxiang Lin; Muran Wang; Zhengzheng Li; Yiyun Weng; Wei Guo; Sergii Vakal; Jiang-Fan Chen
Journal:  J Neuroinflammation       Date:  2022-02-18       Impact factor: 8.322

6.  Neurology at the crossroads.

Authors: 
Journal:  Nat Rev Neurol       Date:  2020-11       Impact factor: 42.937
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.